JACY GAMEIRO

Prof. Dr. JACY GAMEIRO


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Frontiers in Tropical Diseases
Verified
Journal Article
Open access
SSSara Malaguti Andrade Soares
Sara Malaguti Andrade Soares
AGAna Cristina Moura Gualberto
Ana Cristina Moura Gualberto
ACAugusto Cesar da Costa
Augusto Cesar da Costa
DGDiego Assis Gonçalves
Diego Assis Gonçalves
JGJACY GAMEIRO
JACY GAMEIRO
Introduction: It is well known that dietary changes have a significant impact on the immune system, and modifications in lipid balance may contribute to disease progression in several cases. Malaria is still a major global health concern, and the development of the disease has already been linked to the host’s nutritional status, so it’s critical to understand how environmental factors, such as dietary variations, can influence the outcome of infection. We therefore investigated the effect of a short-term diet in a murine model of experimental cerebral malaria.Methods: For this, male C57BL/6 mice were fed a high fat diet containing 60% of the calories from lipids for 5 days. Following this period, the animals were infected with Plasmodium berghei ANKA, and parasitemia, survival, and neurological scores were compared. Considering that one of the first elimination routes of the intracellular parasite is oxidative stress, the antioxidant N-acetylcysteine was administered to assess whether the protection would be reversed.Results and discussion: Animals fed a hyperlipidic diet reacted the same way to infection even after NAC administration. Unlike the control group, which died after eight days of infection with roughly 7% parasitized red blood cells, the hyperlipidic diet group was resistant to infection, with no clinical signs and no increase in blood parasitemia. Several proinflammatory cytokines such as TNF-α IFN-γ and IL-6 were increased in the spleen of both infected groups, regardless of their diet. The provision of a high-fat diet to mice for as little as 5 days completely prevents Plasmodium berghei ANKA infection in C57BL/6 mice, while the treatment of an antioxidant failed to reverse the parasite protection.

8 November 2025 in Bratislava Medical Journal
Verified
Journal Article
Closed access
PDF file
MLMaria Julia Tôrres Lima
Maria Julia Tôrres Lima
LJLuiza Lopes Ricardo Januzzi
Luiza Lopes Ricardo Januzzi
JGJACY GAMEIRO
JACY GAMEIRO

23 September 2026 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Open access
PDF file
MMMaria Júlia Borges Mello
Maria Júlia Borges Mello
BFBárbara Ribeiro Fonseca
Bárbara Ribeiro Fonseca
GSGabriela Coutinho Saceloti
Gabriela Coutinho Saceloti
LCLuciana Debortoli de Carvalho
Luciana Debortoli de Carvalho
BTBordalo Lívia Tonucci
Bordalo Lívia Tonucci
JGJACY GAMEIRO
JACY GAMEIRO
This article addresses extracellular vesicles derived from lactic acid bacteria (LAB-EVs), which have become fundamental mediators of host–microbe communication, yielding new insights about the molecular mechanisms underlying probiotic and postbiotic activity. The review integrates current evidence on the biogenesis, structural characteristics, and functional roles of LAB-EVs, stressing their capacity to transport bioactive cargos - including proteins, nucleic acids, and metabolites - to host cells. We highlight how LAB-EVs interact with the intestinal epithelial barrier, modulate innate and adaptive immune responses, and contribute to the maintenance of mucosal homeostasis. Particular attention is given to signaling pathways mediated by pattern recognition receptors, macrophage polarization, and the regulation of tight junction proteins, which collectively sustain barrier integrity and immune tolerance. Furthermore, we discuss the therapeutic implications of LAB-EVs in inflammatory bowel disease, epithelial repair, and systemic tissue regeneration. Despite these promising findings, significant obstacles remain in standardizing isolation methods, characterizing vesicle heterogeneity, and developing regulatory systems for clinical translation. Conquering these technical and safety barriers will be essential to consolidate LAB-EVs as safe and effective postbiotic tools in microbiome-based therapies. This review provides a discerning perspective on the current state of LAB-EVs research and describes future directions for their use in human health.